Bran and irritable bowel syndrome: The primary-care perspectiveCitation formats

Standard

Bran and irritable bowel syndrome: The primary-care perspective. / Miller, V.; Lea, R.; Agrawal, A.; Whorwell, P. J.

In: Digestive and Liver Disease, Vol. 38, No. 10, 10.2006, p. 737-740.

Research output: Contribution to journalArticle

Harvard

Miller, V, Lea, R, Agrawal, A & Whorwell, PJ 2006, 'Bran and irritable bowel syndrome: The primary-care perspective', Digestive and Liver Disease, vol. 38, no. 10, pp. 737-740. https://doi.org/10.1016/j.dld.2006.06.015

APA

Miller, V., Lea, R., Agrawal, A., & Whorwell, P. J. (2006). Bran and irritable bowel syndrome: The primary-care perspective. Digestive and Liver Disease, 38(10), 737-740. https://doi.org/10.1016/j.dld.2006.06.015

Vancouver

Miller V, Lea R, Agrawal A, Whorwell PJ. Bran and irritable bowel syndrome: The primary-care perspective. Digestive and Liver Disease. 2006 Oct;38(10):737-740. https://doi.org/10.1016/j.dld.2006.06.015

Author

Miller, V. ; Lea, R. ; Agrawal, A. ; Whorwell, P. J. / Bran and irritable bowel syndrome: The primary-care perspective. In: Digestive and Liver Disease. 2006 ; Vol. 38, No. 10. pp. 737-740.

Bibtex

@article{da33ad3087444c2f8f7c5f2971965418,
title = "Bran and irritable bowel syndrome: The primary-care perspective",
abstract = "Background: We have shown that bran exacerbates irritable bowel syndrome symptoms in a large proportion of secondary-care patients. However, it is unknown if this also happens in primary-care or whether a better response to bran occurs, leading to bran failures being selected for referral to the specialist. Aims: To assess the response to bran in primary-care irritable bowel syndrome comparing it to that obtained in secondary-care. Patients and methods: One hundred consecutive primary-care irritable bowel syndrome patients were asked how bran or soluble fibre products affected their symptoms. Results: Bran improved symptoms in 27{\%} of primary-care and 10{\%} of secondary-care patients (p <0.01) and exacerbated symptoms in 22{\%} of primary-care and 55{\%} of secondary-care patients (p <0.001). Fifty-one percent of primary-care and 33{\%} of secondary-care patients reported no change with bran. In primary-care, proprietary fibre led to improvement in 25{\%}, deterioration in 19{\%} and no change in 56{\%} which was not significantly different to secondary-care. Conclusion: Although not especially effective in primary-care irritable bowel syndrome patients, bran does not cause so many problems and is more helpful than in secondary-care. The effects of soluble fibre are similar in both primary-care and secondary-care. This study highlights the problem of extrapolating the response to treatment in irritable bowel syndrome from different care settings. {\circledC} 2006 Editrice Gastroenterologica Italiana S.r.l.",
keywords = "Bran, Fibre, Irritable bowel syndrome, Primary-care",
author = "V. Miller and R. Lea and A. Agrawal and Whorwell, {P. J.}",
year = "2006",
month = "10",
doi = "10.1016/j.dld.2006.06.015",
language = "English",
volume = "38",
pages = "737--740",
journal = "Digestive and Liver Disease",
issn = "1590-8658",
publisher = "Elsevier BV",
number = "10",

}

RIS

TY - JOUR

T1 - Bran and irritable bowel syndrome: The primary-care perspective

AU - Miller, V.

AU - Lea, R.

AU - Agrawal, A.

AU - Whorwell, P. J.

PY - 2006/10

Y1 - 2006/10

N2 - Background: We have shown that bran exacerbates irritable bowel syndrome symptoms in a large proportion of secondary-care patients. However, it is unknown if this also happens in primary-care or whether a better response to bran occurs, leading to bran failures being selected for referral to the specialist. Aims: To assess the response to bran in primary-care irritable bowel syndrome comparing it to that obtained in secondary-care. Patients and methods: One hundred consecutive primary-care irritable bowel syndrome patients were asked how bran or soluble fibre products affected their symptoms. Results: Bran improved symptoms in 27% of primary-care and 10% of secondary-care patients (p <0.01) and exacerbated symptoms in 22% of primary-care and 55% of secondary-care patients (p <0.001). Fifty-one percent of primary-care and 33% of secondary-care patients reported no change with bran. In primary-care, proprietary fibre led to improvement in 25%, deterioration in 19% and no change in 56% which was not significantly different to secondary-care. Conclusion: Although not especially effective in primary-care irritable bowel syndrome patients, bran does not cause so many problems and is more helpful than in secondary-care. The effects of soluble fibre are similar in both primary-care and secondary-care. This study highlights the problem of extrapolating the response to treatment in irritable bowel syndrome from different care settings. © 2006 Editrice Gastroenterologica Italiana S.r.l.

AB - Background: We have shown that bran exacerbates irritable bowel syndrome symptoms in a large proportion of secondary-care patients. However, it is unknown if this also happens in primary-care or whether a better response to bran occurs, leading to bran failures being selected for referral to the specialist. Aims: To assess the response to bran in primary-care irritable bowel syndrome comparing it to that obtained in secondary-care. Patients and methods: One hundred consecutive primary-care irritable bowel syndrome patients were asked how bran or soluble fibre products affected their symptoms. Results: Bran improved symptoms in 27% of primary-care and 10% of secondary-care patients (p <0.01) and exacerbated symptoms in 22% of primary-care and 55% of secondary-care patients (p <0.001). Fifty-one percent of primary-care and 33% of secondary-care patients reported no change with bran. In primary-care, proprietary fibre led to improvement in 25%, deterioration in 19% and no change in 56% which was not significantly different to secondary-care. Conclusion: Although not especially effective in primary-care irritable bowel syndrome patients, bran does not cause so many problems and is more helpful than in secondary-care. The effects of soluble fibre are similar in both primary-care and secondary-care. This study highlights the problem of extrapolating the response to treatment in irritable bowel syndrome from different care settings. © 2006 Editrice Gastroenterologica Italiana S.r.l.

KW - Bran

KW - Fibre

KW - Irritable bowel syndrome

KW - Primary-care

U2 - 10.1016/j.dld.2006.06.015

DO - 10.1016/j.dld.2006.06.015

M3 - Article

VL - 38

SP - 737

EP - 740

JO - Digestive and Liver Disease

JF - Digestive and Liver Disease

SN - 1590-8658

IS - 10

ER -